Search Results - "Omoyege, Deborah"

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB by Giver, Cynthia R., Shaw, Pamela A, Fletcher, Helen, Kaushal, Deepak, Pamela, Garcia, Omoyege, Deborah, Bisson, Gregory, Gumbo, Tawanda, Wallis, Robert, Waller, Edmund K., Kalman, Daniel

“…Background: With existing anti-tubercular therapies, treatment success rates for multi- and extensively-drug resistant tuberculosis (MDR-TB, XDR-TB) are…”
Get full text

Pharmacokinetics of single dose doxycycline in the rectum, vagina, and urethra: implications for prevention of bacterial sexually transmitted infections by Haaland, Richard E., Fountain, Jeffrey, Edwards, Tiancheng E., Dinh, Chuong, Martin, Amy, Omoyege, Deborah, Conway-Washington, Christopher, Kelley, Colleen F., Heneine, Walid

“…Clinical trials showed a single oral dose of doxycycline taken after sex protects against STIs among men who have sex with men (MSM) but not women…”
Get full text

Pharmacokinetics of single dose doxycycline in the rectum, vagina, and urethra: implications for prevention of bacterial sexually transmitted infectionsResearch in context by Richard E. Haaland, Jeffrey Fountain, Tiancheng E. Edwards, Chuong Dinh, Amy Martin, Deborah Omoyege, Christopher Conway-Washington, Colleen F. Kelley, Walid Heneine

“…Background: Clinical trials showed a single oral dose of doxycycline taken after sex protects against STIs among men who have sex with men (MSM) but not women…”
Get full text